Old Web
English
Sign In
Acemap
>
authorDetail
>
Judith A. Fox
Judith A. Fox
Novartis
Medicine
CD33
CD3
Pathology
Antibody
7
Papers
327
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Protéines de liaison cd3 et cd33 bispécifiques
2015
Kristina Ellwanger
Luke Evnin
Judith A. Fox
Ivica Fucek
Jeanmarie Guenot
Stefan Knackmuss
Lori Kunkel
Melvyn Little
Vera Molkenthin
Erich Rajkovic
Uwe Reusch
Claudia Wall
Michael Weichel
Eugene Zhukovsky
Show All
Source
Cite
Save
Citations (0)
Construction and characterization of novel CD33/CD3 tandem diabodies (TandAbs) for the treatment of acute myeloid leukemia (AML).
2015
Journal of Clinical Oncology
Uwe Reusch
Kimberly H. Harrington
Chelsea J. Gudgeon
Ivica Fucek
Kristina Ellwanger
Michael Weichel
Stefan Knackmuss
Eugene Zhukovsky
Judith A. Fox
Jeanmarie Guenot
Roland B. Walter
Show All
Source
Cite
Save
Citations (2)
Voreloxin, a first-in-class anticancer quinolone derivative, in relapsed/refractory solid tumors: a report on two dosing schedules.
2010
Clinical Cancer Research
Ranjana H. Advani
Herbert Hurwitz
Michael S. Gordon
Scot Ebbinghaus
David S. Mendelson
Heather A. Wakelee
Ute Hoch
Jeffrey A. Silverman
Nancy A. Havrilla
C. Berman
Judith A. Fox
Roberta S. Allen
Daniel C. Adelman
Show All
Source
Cite
Save
Citations (39)
A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors
2008
Clinical Cancer Research
Debashis Sarker
R. Molife
T.R. Jeffrey Evans
Maryon Hardie
Cheryl Marriott
Priska Butzberger-Zimmerli
Rosemary Morrison
Judith A. Fox
Carla Heise
Sharianne Louie
Natasha Aziz
Felix Garzon
Glenn Michelson
Ian Judson
Dalal Jadayel
Edgar Braendle
Johann S. de Bono
Show All
Source
Cite
Save
Citations (125)
1